Wednesday, May 14, 2025
spot_img

WithSecure has resolved on a directed share issue

WithSecure Corporation, Stock Exchange Release, 14 May 2025, at 13:00 EEST

WithSecure has resolved on a directed share issue

WithSecure’s Annual General Meeting, held on 18 March 2025, resolved to authorise the Board of Directors to resolve on the issuance of a maximum of 17,609,870 shares. The authorisation entitles the Board of Directors to resolve on the terms related to the share issue. A maximum of 2,000,000 shares may be used as part of share-based incentive schemes. The authorisation is valid until the conclusion of the next Annual General Meeting, in any case no later than until 30 June 2026.

Based on this authorisation, the Board of Directors has resolved on a share issue without consideration as follows:

  1. The number of shares to be issued is 180,445 shares at the most. The shares to be issued are treasury shares.
  2. The shares will be issued to the Board of Directors as part of their compensation (128,221 shares), as well as the recipients of the Restricted Share Plan 2022-2024 reward shares (52,224 shares).
  3. There is a particularly weighty financial reason for deviating from the shareholders’ pre-emptive right as referred to in Chapter 9, Section 4, Paragraph 1 of the Finnish Companies Act given that the shares will be issued as part of the Company’s Board of Directors’ remuneration and share-based incentive schemes.

Changes in own shares will be separately communicated after delivery of the shares.

Contact information:
Laura Viita
VP, Controlling, investor relations and sustainability
WithSecure Corporation
+358 50 487 1044
[email protected]

Powered by SlickText.com

Hot this week

TruGolf Links Signs Newest Franchisee to Begin Developing on Long Island

Iconic Golf Simulator Company Now Franchising Grants Seasoned Healthcare...

Altura Energy Provides Update on Brokered Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR...

Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer

Cannabix has developed an autonomous alcohol breathalyzer screening device...

Therivaâ„¢ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results

- VCN-01 Achieves Primary Efficacy and Safety Endpoints for...

Topics

spot_img

Related Articles

Popular Categories

spot_img